Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Luitpold Pharmaceuticals, a partner of Perrigo, has obtained final approval for Epinastine HCl ophthalmic solution, 0.05%.
Subscribe to our email newsletter
Epinastine HCl is a generic version of Merck’s eye drug Elestat.
Elestat comprises epinastine used to prevent ocular itching associated with allergic conjunctivitis.
Perrigo chairman and CEO Joseph Papa said they were excited to launch another new product in the ophthalmic category as part of their extended topical strategy.
Perrigo manufactures active pharmaceutical ingredients (API), generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products and OTC products.